References
- Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D, et al. The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia. Am J Surg Pathol 2013;37:1469–89.
- Kanayama HO, Fukumori T, Fujimoto H, Nakanishi H, Ohyama C, Suzuki K, et al. Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: the first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association. Int J Urol 2015;22:S1–7.
- Tilki D, Nguyen HG, Dall’Era MA, Bertini R, Carballido JA, Chromecki T, et al. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus. Eur Urol 2014;66:577–83.
- Steffens S, Janssen M, Roos FC, Becker F, Schumacher S, Seidel C, et al. Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma – a multicentre study. Eur J Cancer 2012;48:2347–52.
- Ledezma RA, Negron E, Paner GP, Rjepaj C, Lascano D, Haseebuddin M, et al. Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery. World J Urol 2016;34:687–93.
- Byler TK, Bratslavsky G. Hereditary renal cell carcinoma: genetics, clinical features, and surgical considerations. World J Urol 2014;32:623–30.
- Brookman-May SD, May M, Wolff I, Zigeuner R, Hutterer GC, Cindolo L, et al. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors? Eur Urol 2015;67:943–51.
- Veeratterapillay R, Simren R, El-Sherif A, Johnson MI, Soomro N, Heer R. Accuracy of the revised 2010 TNM classification in predicting the prognosis of patients treated for renal cell cancer in the north east of England. J Clin Pathol 2012;65:367–71.
- Herrmann E, Trojan L, Becker F, Wülfing C, Schrader AJ, Barth P, et al. Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review. J Urol 2010;183:460–6.
- Klatte T, Remzi M, Zigeuner RE, Mannweiler S, Said JW, Kabbinavar FF, et al. Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinoma. J Urol 2010;184:53–8.
- Zucchi A, Novara G, Costantini E, Antonelli A, Carini M, Carmignani G, et al. Prognostic factors in a large multi-institutional series of papillary renal cell carcinoma. BJU Int 2012;109:1140–6.
- Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, et al. The Heidelberg classification of renal cell tumours. J Pathol 1997;183:131–3.
- Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471–4.
- Fuhrman S, Lasky LC, Limas L. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655–63.
- Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statist Med 1996;15:361–87.
- Cornejo KM, Dong F, Zhou AG, Wu CL, Young RH, Braaten K, et al. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome. Hum Pathol 2015;46:1411–17.
- Klatte T, Anterasian C, Said JW, de Martino M, Kabbinavar FF, Belldegrun AS, Pantuck AJ. Fuhrman grade provides higher prognostic accuracy than nucleolar grade for papillary renal cell carcinoma. J Urol 2010;183:2143–7.